Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

m6A RNA modifications: Key regulators of normal and malignant hematopoiesis

Experimental Hematology(2022)10.1016/j.exphem.2022.04.006Source: DataRank Database

m6A RNA modifications: Key regulators of normal and malignant hematopoiesis is a research paper published in Experimental Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 0.24)OA: bronzeTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jessie Brown ORCID,Myriam L. R. Haltalli ORCID,François Mercier ORCID,Ly Vu ORCID,Kamil R. Kranc ORCID

Live enrichment

PubMed:35487293 OpenAlex:https://openalex.org/W4224927195

Medical Research Council

Grant: MC_PC_17230

Medical Research Council

Grant: MR/P010008/1

Medical Research Council

Grant: MR/P010008/2

Cancer Research UK

Grant: C29967/A26787

Cancer Research UK

Grant: 14633

Wellcome Trust

Grant: 203151/Z/16/Z

Barts Charity

Grant: G-002164

NCI NIH HHS

Grant: K99 CA267168

Barts Charity

Grant: MGU0418

Cancer Research UK

Grant: 26787

Barts Charity

Wellcome Trust

CRUK Barts Centre

NIH

UKRI

Blood Cancer UK

Peter und Traudl Engelhorn Stiftung

FWCI

0.24

Citation Percentile

0.5%

Citation Trend

2022

2024

2025

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.exphem.org/article/S0301472X22002041/pdf

BRONZEhttps://doi.org/10.1016/j.exphem.2022.04.006

publisherhttp://www.exphem.org/article/S0301472X22002041/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22002041?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22002041?httpAccept=text/plain

Fields of Study

RNA modifications and cancerCancer-related molecular mechanisms researchCancer-related gene regulationMedicineBiologyHematopoiesisHematopoietic Stem CellsHumansLeukemiaRNARNA Processing, Post-Transcriptional

MeSH Terms

HematopoiesisHematopoietic Stem CellsHumansLeukemiaRNARNA Processing, Post-Transcriptional

Keywords

HaematopoiesisRNABiologyTranslation (biology)Stem cellHematopoietic stem cellCell biologyLeukemiaComputational biologyFunction (biology)Messenger RNACancer researchGeneGenetics

Sustainable Development Goals

SDG 0: Partnerships for the goals